Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingyi Huaji Recipe (QYHJ) is a Traditional Chinese Medicine (TCM) herbal formula specifically developed for the treatment of pancreatic cancer. It is composed of several herbs, including *Scutellaria barbata*, *Oldenlandia diffusa*, *Amorphophallus konjac*, *Arisaema erubescens*, and *Crepis lignea*. QYHJ is primarily used as an adjuvant therapy alongside standard chemotherapy (such as gemcitabine and albumin-bound paclitaxel) to improve clinical outcomes, reduce toxicity, and inhibit tumor progression. Its mechanism of action involves modulating the tumor microenvironment, inhibiting epithelial-mesenchymal transition (EMT), and inducing apoptosis in pancreatic cancer cells. It has been extensively studied at the Fudan University Shanghai Cancer Center.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qingyi Huaji Recipe.